Understanding Rheumatoid Arthritis Types: Classification by Serology, Pattern, and Course

RA Classification: Multiple Overlapping Dimensions

No single typology captures RA heterogeneity. Clinicians use serology, joint pattern, disease stage, and erosiveness concurrently.

1. By Serostatus (Most Fundamental)

• Seropositive RA (~70–80%): RF+ and/or anti-CCP+. More erosive, extra-articular manifestations, nodules, worse prognosis.
• Seronegative RA (~20–30%): RF– and anti-CCP–. Milder erosions, but still progressive. Diagnosis by clinical + imaging + exclusion.

2. By Disease Duration/Stage

• Early RA: Symptom onset <6 months (some use <12 mo). Critical treatment window.
• Established RA: >6–12 months. May have erosions, functional impairment.

3. By Joint Distribution

• Polyarticular (≥5 joints): Most common. Small joints (MCP, PIP, wrist, MTP) + large.
• Oligoarticular (2–4 joints): Less common. Can evolve to polyarticular.
• Monoarticular: Rare; consider crystal, infection, spondyloarthritis.
• Symmetrical: Classic RA (both wrists, MCPs). Asymmetry suggests PsA, Lyme, crystal.
• Palindromic rheumatism: Recurrent brief attacks, no residual damage—may evolve to RA.

4. By Erosive Status

• Erosive RA: Radiographic erosions (baseline or developing). Higher disability risk.
• Non-erosive RA: No erosions on imaging. Better prognosis but still needs treatment.

5. By Disease Activity & Course

• Remitting: Sustained low activity (with/without meds).
• Relapsing-remitting: Flares interspersed with control.
• Persistent high activity: Despite therapy—"difficult-to-treat RA."
• Rapid radiographic progression: Genetic (SE alleles), high seropositivity, smoking.

6. Special Populations

• Juvenile Idiopathic Arthritis (JIA): Onset <16 yrs. Subtypes: oligo, poly (RF±), systemic, enthesitis-related, psoriatic, undifferentiated.
• Elderly-onset RA (EORA): Onset >65. More large joints, polymyalgia-like, higher seronegativity.
• RA with interstitial lung disease (RA-ILD): Poor prognosis; avoids MTX/TNFi.
• Felty's syndrome: RA + splenomegaly + neutropenia.
• Rheumatoid vasculitis: Severe extra-articular; cutaneous, nerve, visceral.

Clinical Utility

Typing guides: prognosis counseling, DMT selection (e.g., avoid TNFi in ILD, prefer rituximab in seropositive), monitoring intensity, comorbidity screening.